DNA copy-number loss on 1p36.1 harboring runx3 with promoter hypermethylation and associated loss of runx3 expression in liver fluke-associated intrahepatic cholangiocarcinoma

Asian Pacific Journal of Cancer Prevention

Volumn 10, Issue 4, 2009, Pages 575-582

  Dachrut, Somkid ^a,b,c   Banthaisong, S ^a   Sripa, M ^a   Paeyao, A ^b   Ho, C ^d   Lee, S A ^d   Kosinski, C ^d   Patil, M A ^d   Zhang, J ^e   Chen, X ^a,d   Sripa, Banchob ^a,b   Pairojkul, Chawalit ^a,b  

^a KHON KAEN UNIVERSITY   (Thailand)

^b KHON KAEN UNIVERSITY   (Thailand)

^c WALAILAK UNIVERSITY   (Thailand)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e PEKING UNIVERSITY CANCER HOSPITAL AND INSTITUTE   (China)

Author keywords

Chromosome 1p36; DNA hypermethylation; Microarray comparative genomic hybridization; RUNX3

Indexed keywords

EID: 77951130740     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (66)

1. Akahira J, Suzuki F, Suzuki T, et al (2007). Decreased expression of RIZ1 and its clinicopathological significance in epithelial ovarian carcinoma: correlation with epigenetic inactivation by aberrant DNA methylation. Pathol Int, 57, 725-33.
2. Anglin I, Passaniti A (2004). Runx protein signaling in human cancers. Cancer Treat Res, 119, 189-215.
3. Bae SC, Choi JK (2004). Tumor suppressor activity of RUNX3. Oncogene, 23, 4336-40.
4. Baylin SB, Ohm JE (2006). Epigenetic gene silencing in cancer -a mechanism for early oncogenic pathway addiction? Nat Rev Cancer, 6, 107-16.
5. Cameron ER, Blyth K, Hanlon L, et al (2003). The Runx genes as dominant oncogenes. Blood Cells Mol Dis, 30, 194-200.
6. Caren H, Ejeskar K, Fransson S, et al (2005). A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation. Mol Cancer, 4, 10.
7. Coe BP, Henderson LJ, Garnis C, et al (2005). High-resolution chromosome arm 5p array CGH analysis of small cell lung carcinoma cell lines. Genes Chromosomes Cancer, 42, 308-13.
8. Cooke SL, Pole JC, Chin SF, et al (2008). High-resolution array CGH clarifies events occurring on 8p in carcinogenesis. BMC Cancer, 8, 288.
9. Endo K, Ashida K, Miyake N, Terada T (2001). E-cadherin gene mutations in human intrahepatic cholangiocarcinoma. J Pathol, 193, 310-7.
10. Fang W, Piao Z, Simon D, Sheu JC, Huang S (2000). Mapping of a minimal deleted region in human hepatocellular carcinoma to 1p36.13-p36.23 and mutational analysis of the RIZ (PRDM2) gene localized to the region. Genes Chromosomes Cancer, 28, 269-275.
11. Fukamachi H (2006). Runx3 controls growth and differentiation of gastric epithelial cells in mammals. Dev Growth Differ, 48, 1-13.
12. Fukamachi H, Ito K, Ito Y (2004). Runx3-/-gastric epithelial cells differentiate into intestinal type cells. Biochem Biophys Res Commun, 321, 58-64.
13. Geli J, Nord B, Frisk T, et al (2005). Deletions and altered expression of the RIZ1 tumour suppressor gene in 1p36 in pheochromocytomas and abdominal paragangliomas. Int J Oncol, 26, 1385-91.
14. Harada T, Chelala C, Crnogorac-Jurcevic T, Lemoine NR (2009). Genome-wide analysis of pancreatic cancer using microarray-based techniques. Pancreatology, 9, 13-24.
15. Hasegawa K, Yazumi S, Wada M, et al (2007). Restoration of RUNX3 enhances transforming growth factor-betadependent p21 expression in a biliary tract cancer cell line. Cancer Sci, 98, 838-43.
16. Horsley SW, Mackay A, Iravani M, et al (2006). Array CGH of fusion gene-positive leukemia-derived cell lines reveals cryptic regions of genomic gain and loss. Genes Chromosomes Cancer, 45, 554-64.
17. Hosoda M, Ozaki T, Miyazaki K, et al (2005). UFD2a mediates the proteasomal turnover of p73 without promoting p73 ubiquitination. Oncogene, 24, 7156-69.
18. Huang S (1999). The retinoblastoma protein-interacting zinc finger gene RIZ in 1p36-linked cancers. Front Biosci, 4, D528-32.
19. Hussenet T, Mallem N, Redon R, et al (2006). Overlapping 3q28 amplifications in the COMA cell line and undifferentiated primary sarcoma. Cancer Genet Cytogenet, 169, 102-13.
20. Hwang KT, Han W, Bae JY, et al (2007). Downregulation of the RUNX3 gene by promoter hypermethylation and hemizygous deletion in breast cancer. J Korean Med Sci, 22 Suppl, S24-31.
21. Ito Y (2004) Oncogenic potential of the RUNX gene family: 'overview'. Oncogene, 23, 4198-208.
22. Ito Y, Miyazono K (2003). RUNX transcription factors as key targets of TGF-beta superfamily signaling. Curr Opin Genet Dev, 13, 43-7.
23. Ito Y, Osato M, Ito K (2003). RUNX and cancer. Ann Acad Med Singapore, 32 (5 Suppl), S6-7.
24. Jones PA, Laird PW (1999). Cancer epigenetics comes of age. Nat Genet, 21, 163-7.
25. Kiba T, Tsuda H, Pairojkul C, et al (1993). Mutations of the p53 tumor suppressor gene and the ras gene family in intrahepatic cholangiocellular carcinomas in Japan and Thailand. Mol Carcinog, 8, 312-8.
26. Kim TY, Lee HJ, Hwang KS, et al (2004). Methylation of RUNX3 in various types of human cancers and premalignant stages of gastric carcinoma. Lab Invest, 84, 479-84.
27. Kim WJ, Kim EJ, Jeong P, et al (2005). RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors. Cancer Res, 65, 9347-54.
28. Khan SA, Thomas HC, Davidson BR, Taylor-Robinson SD (2005). Cholangiocarcinoma. Lancet, 366, 1303-14.
29. Lefeuvre M, Gunduz M, Nagatsuka H, Gunduz E, Al Sheikh Ali M, Beder L, et al (2009). Fine deletion analysis of 1p36 chromosomal region in oral squamous cell carcinomas. J Oral Pathol Med, 38, 94-8.
30. Li Y, Du X, Li F, Deng Y, Yang Z, Wang Y, et al (2006). A novel zinc-finger protein ZNF436 suppresses transcriptional activities of AP-1 and SRE. Mol Biol Rep, 33, 287-94.
31. Limpaiboon T, Khaenam P, Chinnasri P, et al (2005). Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma. Cancer Lett, 217, 213-9.
32. Limpaiboon T, Tapdara S, Jearanaikoon P, Sripa B, Bhudhisawasdi V (2006). Prognostic significance of microsatellite alterations at 1p36 in cholangiocarcinoma. World J Gastroenterol, 12, 4377-82.
33. Liu XF, Zhang H, Zhu SG, et al (2006). Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma. World J Gastroenterol, 12, 4706-9.
34. Lockwood WW, Coe BP, et al (2007). Whole genome tiling path array CGH analysis of segmental copy number alterations in cervical cancer cell lines. Int J Cancer, 120, 436-43.
35. McMillan JR, Haftek M, Akiyama M, et al (2003). Alterations in desmosome size and number coincide with the loss of keratinocyte cohesion in skin with homozygous and heterozygous defects in the desmosomal protein plakophilin 1. J Invest Dermatol, 121, 96-103.
36. Missiaglia E, Selfe J, Hamdi M, et al (2009). Genomic imbalances in rhabdomyosarcoma cell lines affect expression of genes frequently altered in primary tumors: an approach to identify candidate genes involved in tumor development. Genes Chromosomes Cancer, 48, 455-67.
37. Miyagawa K, Sakakura C, Nakashima S, et al (2006). Down-regulation of RUNX1, RUNX3 and CBFbeta in hepatocellular carcinomas in an early stage of hepatocarcinogenesis. Anticancer Res, 26, 3633-43.
38. Miyazono K, Maeda S, Imamura T (2004). Coordinate regulation of cell growth and differentiation by TGF-beta superfamily and Runx proteins. Oncogene, 23, 4232-4237.
39. Miyazono K, Suzuki H, Imamura, T (2003). Regulation of TGF-beta signaling and its roles in progression of tumors. Cancer Sci, 94, 230-234.
40. Muller P, Henn W, Niedermayer I, et al (1999). Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Cancer Res, 5, 3569-77.
41. Murnane JP (2006). Telomeres and chromosome instability. DNA Repair, 5, 1082-92.
42. Nellore A, Paziana K, Ma C, et al (2009). Loss of Rap1GAP in papillary thyroid cancer. J Clin Endocrinol Metab, 94, 1026-32.
43. Or YY, Hui AB, Tam KY, Huang DP, Lo KW (2005). Characterization of chromosome 3q and 12q amplicons in nasopharyngeal carcinoma cell lines. Int J Oncol, 26, 49-56.
44. Park SR, Lee EK, Kim BC, Kim PH (2003). p300 cooperates with Smad3/4 and Runx3 in TGFbeta1-induced IgA isotype expression. Eur J Immunol, 33, 3386-92.
45. Piao GH, Piao WH, He Y, et al (2008). Hyper-methylation of RIZ1 tumor suppressor gene is involved in the early tumorigenesis of hepatocellular carcinoma. Histol Histopathol, 23, 1171-5.
46. Rosenbluth JM, Pietenpol JA (2008). The jury is in: p73 is a tumor suppressor after all. Genes Dev, 22, 2591-5.
47. Saito S, Ghosh M, Morita K, et al (2006). The genetic differences between gallbladder and bile duct cancer cell lines. Oncol Rep, 16, 949-56.
48. Seo GY, Park SR, Kim PH (2009). Analyses of TGF-beta1-inducible Ig germ-line gamma2b promoter activity: involvement of Smads and NF-kappaB. Eur J Immunol, 39, 1157-66.
49. Shann YJ, Cheng C, Chiao CH, et al (2008). Genome-wide mapping and characterization of hypomethylated sites in human tissues and breast cancer cell lines. Genome Res, 18, 791-801.
50. Suzuki M, Shigematsu H, Shames DS, et al (2005). DNA methylation-associated inactivation of TGFbeta-related genes DRM/Gremlin, RUNX3, and HPP1 in human cancers. Br J Cancer, 93, 1029-37.
51. Takada H, Imoto I, Tsuda H, et al (2005). Screening of DNA copy-number aberrations in gastric cancer cell lines by array-based comparative genomic hybridization. Cancer Sci, 96, 100-10.
52. Takahashi Y, Kawate S, Watanabe M, et al (2007). Amplification of c-myc and cyclin D1 genes in primary and metastatic carcinomas of the liver. Pathol Int, 57, 437-42.
53. Tannapfel A, Benicke M, Katalinic A, et al (2000). Frequency of p16(INK4A) alterations and K-ras mutations in intrahepatic cholangiocarcinoma of the liver. Gut, 47, 721-7.
54. Tokumaru Y, Nomoto S, Jeronimo C, et al (2003). Biallelic inactivation of the RIZ1 gene in human gastric cancer. Oncogene, 22, 6954-8.
55. Tomasini R, Tsuchihara K, Wilhelm M, et al (2008). TAp73 knockout shows genomic instability with infertility and tumor suppressor functions. Genes Dev, 22, 2677-91.
56. Torquati A, O'Rear L, Longobardi L, et al (2004). RUNX3 inhibits cell proliferation and induces apoptosis by reinstating transforming growth factor beta responsiveness in esophageal adenocarcinoma cells. Surgery, 136, 310-6.
57. Tsygankova OM, Prendergast GV, Puttaswamy K, et al (2007). Downregulation of Rap1GAP contributes to Ras transformation. Mol Cell Biol, 27, 6647-58.
58. Ukita Y, Kato M, Terada T (2002). Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry. J Hepatol, 36, 780-5.
59. Wada M, Yazumi S, Takaishi S, et al (2004). Frequent loss of RUNX3 gene expression in human bile duct and pancreatic cancer cell lines. Oncogene, 23, 2401-7.
60. Wattanasirichaigoon S, Tasanakhajorn U, Jesadapatarakul S (1998).The incidence of K-ras codon 12 mutations in cholangiocarcinoma detected by polymerase chain reaction technique. J Med Assoc Thai, 81, 316-23.
61. Xiao W H, Liu WW (2004). Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J Gastroenterol, 10, 376-80.
62. Yanada M, Yaoi T, Shimada J, et al (2005). Frequent hemizygous deletion at 1p36 and hypermethylation downregulate RUNX3 expression in human lung cancer cell lines. Oncol Rep, 14, 817-22.
63. Zhang F, Hamanaka RB, Bobrovnikova-Marjon E, et al (2006). Ribosomal stress couples the unfolded protein response to p53-dependent cell cycle arrest. J Biol Chem, 281, 30036-45.
64. Zhang L, Chenwei L, Mahmood R, et al (2006). Identification of a putative tumor suppressor gene Rap1GAP in pancreatic cancer. Cancer Res, 66, 898-906.
65. Zhang Z, Mitra RS, Henson BS, et al (2006). Rap1GAP inhibits tumor growth in oropharyngeal squamous cell carcinoma. Am J Pathol, 168, 585-96.
66. Zheng H, Gao L, Feng Y, Yuan L, Zhao H, Cornelius LA (2009). Down-regulation of Rap1GAP via promoter hypermethylation promotes melanoma cell proliferation, survival, and migration. Cancer Res, 69, 449-57.